Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart C — Microbiology Devices](/submissions/MI/subpart-c%E2%80%94microbiology-devices) → [21 CFR 866.2660](/submissions/MI/subpart-c%E2%80%94microbiology-devices/866.2660) → OMN — C. Difficile Nucleic Acid Amplification Test Assay

# OMN · C. Difficile Nucleic Acid Amplification Test Assay

_Microbiology · 21 CFR 866.2660 · Class 1_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-c%E2%80%94microbiology-devices/OMN

## Overview

- **Product Code:** OMN
- **Device Name:** C. Difficile Nucleic Acid Amplification Test Assay
- **Regulation:** [21 CFR 866.2660](/submissions/MI/subpart-c%E2%80%94microbiology-devices/866.2660)
- **Device Class:** 1
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

A microorganism differentiation and identification device is a device intended for medical purposes that consists of one or more components, such as differential culture media, biochemical reagents, and paper discs or paper strips impregnated with test reagents, that are usually contained in individual compartments and used to differentiate and identify selected microorganisms. The device aids in the diagnosis of disease.

## Classification Rationale

Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Recent Cleared Devices (5 of 5)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN120013](https://fda.innolitics.com/submissions/MI/subpart-c%E2%80%94microbiology-devices/OMN/DEN120013.md) | PORTRAIT ANALYZER | Great Basin Scientific | Apr 30, 2012 | DENG |
| [K113433](https://fda.innolitics.com/submissions/MI/subpart-c%E2%80%94microbiology-devices/OMN/K113433.md) | SIMPLEXA C. DIFFICILE UNIVERSAL DIRECT | Focus Diagnostics, Inc. | Apr 4, 2012 | SESE |
| [K110203](https://fda.innolitics.com/submissions/MI/subpart-c%E2%80%94microbiology-devices/OMN/K110203.md) | XPERT C. DIFFICLE/EPI ASSAY | Cepheid | Apr 7, 2011 | SESE |
| [K110012](https://fda.innolitics.com/submissions/MI/subpart-c%E2%80%94microbiology-devices/OMN/K110012.md) | ILLUMIGENE C. DIFFICILE, AND ILLUMIPRO-10 | Meridian Bioscience, Inc. | Feb 24, 2011 | SESE |
| [K100818](https://fda.innolitics.com/submissions/MI/subpart-c%E2%80%94microbiology-devices/OMN/K100818.md) | ILLUMIGENE C. DIFFICILE, ILLUMIPRO-10 AND ILLUMIGENE C. DIFFICILE EXTERNAL CONTROL KIT, MODELS 280050, 610172, 279920 | Meridian Bioscience, Inc. | Jul 9, 2010 | SESE |

## Top Applicants

- Meridian Bioscience, Inc. — 2 clearances
- Cepheid — 1 clearance
- Focus Diagnostics, Inc. — 1 clearance
- Great Basin Scientific — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-c%E2%80%94microbiology-devices/OMN](https://fda.innolitics.com/submissions/MI/subpart-c%E2%80%94microbiology-devices/OMN)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com